Hengkang Medical Group Co Ltd
SZSE:002219

Watchlist Manager
Hengkang Medical Group Co Ltd Logo
Hengkang Medical Group Co Ltd
SZSE:002219
Watchlist
Price: 2.61 CNY -5.43% Market Closed
Market Cap: 8.6B CNY
Have any thoughts about
Hengkang Medical Group Co Ltd?
Write Note

Hengkang Medical Group Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hengkang Medical Group Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hengkang Medical Group Co Ltd
SZSE:002219
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hengkang Medical Group Co Ltd
Glance View

Market Cap
8.9B CNY
Industry
Health Care

Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 7,622 full-time employees. The company went IPO on 2008-03-06. In addition, The Company also engages in the research and development, production and manufacture of Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, medical devices, medical institution preparations, daily chemicals and health products. The firm operates its business within the domestic market and overseas markets.

Intrinsic Value
2.21 CNY
Overvaluation 15%
Intrinsic Value
Price

See Also

Back to Top